Platelet sequestration with a new-generation autotransfusion device

Transfusion

Volumn 58, Issue 4, 2018, Pages 989-997

  Seyfried, Timo F ^a   Streithoff, Fabian ^b   Gruber, Michael ^a   Unterbuchner, Christoph ^a   Zech, Nina ^a   Kieninger, Martin ^a   Hansen, Ernil ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b LVA Ndb/Opf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; PADGEM PROTEIN; PPBP PROTEIN, HUMAN;

ARTICLE; BLOOD DONOR; CELL DAMAGE; CELL VIABILITY; HEMATOLOGICAL PROCEDURE; HYPOOSMOTIC STRESS; PLATELET SEQUESTRATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE STRUCTURE; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD STORAGE; CELL SHAPE; CYTOLOGY; DEVICES; DRUG EFFECT; EQUIPMENT DESIGN; HUMAN; OSMOTIC PRESSURE; PROCEDURES; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

BETA-THROMBOGLOBULIN; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD TRANSFUSION, AUTOLOGOUS; CELL SHAPE; EQUIPMENT DESIGN; HUMANS; OSMOTIC PRESSURE; P-SELECTIN; PLATELET AGGREGATION; PLATELET-RICH PLASMA;

EID: 85041178234     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14491     Document Type: Article

References (37)

1. Waters JH. Intraoperative blood recovery. ASAIO J 2013;59:11-7.
2. Zhou SF, Estrera AL, Loubser P, et al. Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial. Ann Thorac Surg 2015;99:1282-90.
3. DelRossi AJ, Cernaianu AC, Vertrees RA, et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;100:281-6.
4. Stammers AH, Kratz J, Johnson T, et al. Hematological assessment of patients undergoing plasmapheresis during cardiac surgery. J Extra Corpor Technol 1993;25:6-14.
5. Christenson JT, Reuse J, Badel P, et al. Autologous platelet sequestration in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 1996;10:1083-9.
6. Schill DM. Plasma sequestration: a good therapy to prevent the deleterious effect of clopidogrel when clopidogrel is used within one to four days of coronary bypass surgery. Perfusion 2010;25:91-5.
7. Everts PA, Hoffmann J, Weibrich G, et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 2006;16:363-8.
8. Piccin A, Di Pierro AM, Canzian L, et al. Platelet gel: a new therapeutic tool with great potential. Blood Transfus 2016;15:333-40.
9. Bausset O, Giraudo L, Veran J, et al. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access 2012;1:115-23.
10. Kirmani BH, Jones SG, Datta S, et al. A meta-analysis of platelet gel for prevention of sternal wound infections following cardiac surgery. Blood Transfus 2016;15:57-65.
11. Patel AN, Selzman CH, Kumpati GS, et al. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg 2016;11:62.
12. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529-35.
13. Rossi LA, Molina Romoli AR, Bertona Altieri BA, et al. Does platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2016;25:3319-25.
14. Scholz M, Serrick C, Noel D, et al. A prospective comparison of the platelet sequestration ability of three autotransfusion devices. J Extra Corpor Technol 2005;37:286-9.
15. Hansen E, Bechmann V, Altmeppen J, et al. Quality management in blood salvage: implementation of quality assurance and variables affecting product quality. Transfus Med Hemother 2004;31:221-7.
16. Holme S. Storage and quality assessment of platelets. Vox Sang 1998;74:207-16.
17. Gruber M, Breu A, Frauendorf M, et al. Washing of banked blood by three different blood salvage devices. Transfusion 2013;53:1001-9.
18. Waters JH, Roberts KC. Database review of possible factors influencing point-of-care platelet gel manufacture. J Extra Corpor Technol 2004;36:250-4.
19. Carless PA, Rubens FD, Anthony DM, et al. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;3:CD004172.
20. Everts PA, Knape JT, Weibrich G, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006;38:174-87.
21. Everts PA, Brown Mahoney C, Hoffmann JJ, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006;24:165-71.
22. Sabarish R, Lavu V, Rao SR. A comparison of platelet count and enrichment percentages in the platelet rich plasma (PRP) obtained following preparation by three different methods. J Clin Diagn Res 2015;9:ZC10-2.
23. Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013;4:67.
24. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg 2014;7:189-97.
25. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994;8:29-36.
26. van der Meer PF, Cancelas JA, Vassallo RR, et al. Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma. Transfusion 2011;51Suppl1:45S-9S.
27. Bausset O, Magalon J, Giraudo L, et al. Impact of local anaesthetics and needle calibres used for painless PRP injections on platelet functionality. Muscles Ligaments Tendons J 2014;4:18-23.
28. Schippinger G, Pruller F, Divjak M, et al. Autologous platelet-rich plasma preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function. Orthop J Sports Med 2015;3:2325967115588896.
29. Perez AG, Lana JF, Rodrigues AA, et al. Relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol 2014;2014:176060.
30. Tynngard N, Lindahl TL, Trinks M, et al. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods. Transfusion 2008;48:715-22.
31. Maurer-Spurej E, Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfus Med Rev 2007;21:295-306.
32. Fairbanks VF, Ziesmer SC, O'Brien PC. Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem 1992;38:132-40.
33. Joergensen MK, Bathum L. Reference intervals for mean platelet volume and immature platelet fraction determined on a Sysmex XE5000 hematology analyzer. Scand J Clin Lab Invest 2016;76:172-6.
34. Riondino S, Martini F, La Farina F, et al. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Clin Biochem 2010;43:666-70.
35. Jespersen J, Bertina RM, Haverkate F. ECAT assay procedures a manual of laboratory techniques. European Concerted Action on Thrombosis and Disabilities of the Commission of the European Communities; 1992. p. 21-34.
36. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
37. Olson JD, Brockway WJ, Fass DN, et al. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. Am J Clin Pathol 1975;63:210-8.